Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease

British Journal of Pharmacology

Volumn 171, Issue 17, 2014, Pages 4073-4086

  Dou, Xiaobing ^a   Xia, Yongliang ^a   Chen, Jing ^a   Qian, Ying ^a   Li, Songtao ^a   Zhang, Ximei ^a   Song, Zhenyuan ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

HSL; methionine; PP2A; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETAINE; HORMONE SENSITIVE LIPASE; METHIONINE; PHOSPHOPROTEIN PHOSPHATASE 2A; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; TRIACYLGLYCEROL;

3T3 CELL LINE; ADIPOCYTE; ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; C57BL 6 MOUSE; CONTROLLED STUDY; FATTY LIVER; LIPID STORAGE; LIPOLYSIS; LIVER PROTECTION; LONG TERM EXPOSURE; MALE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROTECTION; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; LIVER DISEASES, ALCOHOLIC; METABOLISM; PATHOLOGY;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; BETAINE; CELLS, CULTURED; CYTOPROTECTION; DISEASE MODELS, ANIMAL; HEP G2 CELLS; HUMANS; LIPOLYSIS; LIVER DISEASES, ALCOHOLIC; MALE; METHYLATION; MICE; MICE, INBRED C57BL;

EID: 84906061009     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12765     Document Type: Article

References (45)

1. Anthonsen MW, Rönnstrand L, Wernstedt C, Degerman E, Holm C, (1998). Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 273: 215-221.
2. Birner-Gruenberger R, Susani-Etzerodt H, Waldhuber M, Riesenhuber G, Schmidinger H, Rechberger G, et-al. (2005). The lipolytic proteome of mouse adipose tissue. Mol Cell Proteomics 4: 1710-1717.
3. Chen X, Sebastian BM, Nagy LE, (2007). Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am J Physiol Endocrinol Metab 292: E621-E628.
4. Craig SA, (2004). Betaine in human nutrition. Am J Clin Nutr 80: 539-549.
5. Fischer M, You M, Matsumoto M, Crabb DW, (2003). Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 278: 27997-28004.
6. Graf D, Kurz AK, Reinehr R, Fischer R, Kircheis G, Haussinger D, (2002). Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 36: 829-839.
7. Gu D, Wang Z, Dou X, Zhang X, Li S, Vu L, et-al. (2013). Inhibition of ERK1/2 pathway suppresses adiponectin secretion via accelerating protein degradation by Ubiquitin-proteasome system: relevance to obesity-related adiponectin decline. Metabolism 62: 1137-1148.
8. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G, (2010). Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 340: c1240.
9. Haystead TA, Sim AT, Carling D, Honnor RC, Tsukitani Y, Cohen P, et-al. (1989). Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337: 78-781.
10. Janssens V, Goris J, (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353: 417-439.
11. Ji C, Kaplowitz N, (2003). Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124: 1488-1499.
12. Ji C, Chan C, Kaplowitz N, (2006). Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol 45: 717-724.
13. Kang L, Chen X, Sebastian BM, Pratt BT, Bederman IR, Alexander JC, et-al. (2007). Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J Biol Chem 282: 28465-28473.
14. Kathirvel E, Morgan K, Nandgiri G, Sandoval BC, Caudill MA, Bottiglieri T, et-al. (2010). Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol 299: G1068-G1077.
15. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
16. Kwon do Y, Jung YS, Kim SJ, Park HK, Park JH, Kim YC, (2009). Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J Nutr 139: 63-68.
17. Li J, Li XM, Caudill M, Malysheva O, Bardag-Gorce F, Oliva J, et-al. (2011). Betaine feeding prevents the blood alcohol cycle in rats fed alcohol continuously for 1-month using the rat intragastric tube feeding model. Exp Mol Pathol 91: 540-547.
18. Loomba R, Bettencourt R, BarrettConnor E, (2009). Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther 30: 1137-1149.
19. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
20. O'Shea RS, Dasarathy S, McCullough AJ,; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology (2010). Alcoholic liver disease. Hepatology 51: 307-328.
21. Perrotti D, Neviani P, (2013). Protein phosphatase 2A: a target for anticancer therapy. Lancet Oncol 14: e229-e238.
22. Reddy JK, Rao MS, (2006). Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290: G852-G858.
23. Sanyal AJ, (2005). Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2: 46-53.
24. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, et-al. (2006). Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281: 40236-40241.
25. Sebastian BM, Roychowdhury S, Tang H, Hillian AD, Feldstein AE, Stahl GL, et-al. (2011). Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice. J Biol Chem 286: 35989-35997.
26. Shen Z, Li Y, Yu C, Shen Y, Xu L, Xu C, et-al. (2010). A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels. Eur J Gastroenterol Hepatol 22: 820-825.
27. Song Z, Deaciuc I, Zhou Z, Song M, Chen T, Hill D, et-al. (2007). Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 293: G894-G902.
28. Song Z, Zhou Z, Deaciuc I, Chen T, McClain CJ, (2008). Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 47: 867-879.
29. Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordoñez-Llanos J, et-al. (2005). A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 76: 925-933.
30. Stanevich V, Jiang L, Satyshur KA, Li Y, Jeffrey PD, Li Z, et-al. (2011). The structural basis for tight control of PP2A methylation and function by LCMT-1. Mol Cell 41: 331-342.
31. Stewart S, Jones D, Day CP, (2001). Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med 7: 408-413.
32. Sugimoto T, Yamashita S, Ishigami M, Sakai N, Hirano K, Tahara M, et-al. (2002). Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. J Hepatol 36: 157-162.
33. Sun X, Tang Y, Tan X, Li Q, Zhong W, Sun X, et-al. (2012). Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol 302: G548-G557.
34. Tang H, Sebastian BM, Axhemi A, Chen X, Hillian AD, Jacobsen DW, et-al. (2007). Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcohol Clin Exp Res 36: 214-222.
35. Tsai J, Ford ES, Zhao G, Li C, Greenlund KJ, Croft JB, (2011). Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults. J Behav Med 35: 200-210.
36. Wang Z, Yao T, Pini M, Zhou Z, Fantuzzi G, Song Z, (2010). Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 298: G634-G642.
37. Wang Z, Dou X, Yao T, Song Z, (2011). Homocysteine inhibits adipogenesis in 3T3-L1 preadipocytes. Exp Biol Med (Maywood) 236: 1379-1388.
38. Wood SL, Emmison N, Borthwick AC, Yeaman SJ, (1993). The protein phosphatases responsible for dephosphorylation of hormone-sensitive lipase in isolated rat adipocytes. Biochem J 295: 531-535.
39. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ, (2003). The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112: 91-100.
40. Xu J, Lai KK, Verlinsky A, Lugea A, French SW, Cooper MP, et-al. (2011). Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 55: 673-682.
41. You M, Fischer M, Deeg MA, Crabb DW, (2002). Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277: 29342-29347.
42. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW, (2004). The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127: 1798-8084.
43. Zhang W, Wang LW, Wang LK, Li X, Zhang H, Luo LP, et-al. (2013). Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and toll-like receptor 4 expression in rats. Dig Dis Sci 58: 3198-3206.
44. Zhang X, Wang Z, Li J, Gu D, Li S, Shen C, et-al. (2013). Increased 4-hydroxynonenal formation contributes to obesity-related lipolytic activation in adipocytes. PLoS ONE 8: e70663.
45. Zhong W, Zhao Y, Tang Y, Wei X, Shi X, Sun W, et-al. (2012). Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol 180: 998-1007.